Published on May 5, 2012 at 5:14 AM
The article also discusses how GAVI used an advanced market commitment (AMC) from GlaxoSmithKline and Pfizer to encourage investment in creating a pneumococcal vaccine specifically for the developing world. This system of constructing an artificial market "has led to accusations that GAVI is encouraging business to profit from the poorest," the Guardian writes. But GAVI CEO Seth Berkley said, "[T]here are children today who are alive because that vaccine was developed. Do you wait for other companies to come, and would the other companies have been interested if it wasn't for those big guys? I would love to use the AMC again" (Hirsch, 5/3). The ONE blog features a video of the launch of the campaign (Chapman, 5/3).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|